AFT Pharmaceuticals

AFT is a growing multinational pharmaceutical company that develops, markets and distributes a broad portfolio of pharmaceutical products across a wide range of therapeutic categories which are distributed across all major pharmaceutical distribution channels: over-the-counter, prescription and hospital. AFT's product portfolio comprises both proprietary and in-licensed products, and includes patented, branded and generic drugs.


Company Details

Registered Office: Level 1, 129 Hurstmere Road, Takapuna, Auckland 0622
Postal Address: Level 1, 129 Hurstmere Road, Takapuna, Auckland 0622
Telephone: +64 9 488 0232
Facsimile: n/a
Website: www.aftpharm.com
First Listed: 22/12/2015
Balance Date: 31 March
AGM: 04/08/2023

Directors and Executives

Hartley Atkinson
Executive Director
Marree Atkinson
Executive Director
Anita Baldauf
Independent Director
David Flacks
Chairman
Andrew Lane
Director
Malcolm Tubby
CFO / Company Secretary
Ted Witek
Independent Non-Executive Director

Announcements

Title Date Type
Disclosure of Directors and Senior Managers Relevant Intere Fri, Jul 04 2025 08:30 am SHINTR
June Quarter FY 2026 Investor Update Tue, Jul 01 2025 08:35 am GENERAL
Disclosure of Directors and Senior Managers Relevant Intere Fri, Jun 27 2025 08:42 am SHINTR
Notice of Annual Meeting of Shareholders 2025 Fri, Jun 27 2025 08:39 am MEETING
Annual Meeting and Closing Date for Director Nominations Fri, May 30 2025 08:59 am MEETING
AFT and Hikma extend US Maxigesic Cooperation Mon, May 26 2025 08:38 am GENERAL
Corrected Distribution Notice Thu, May 22 2025 12:18 pm CORPACT
AFT sees strong FY 26 as revenue reaches new record Thu, May 22 2025 08:30 am FLLYR
AFT to announce full year results on Thursday May 22 2025 Thu, May 01 2025 08:48 am GENERAL
March investor update Mon, Mar 31 2025 10:03 am GENERAL

Major Holdings Announcements

Date Name No. Held % Current
16/09/20 Forsyth Barr Group Limited and Fors 1,617,818 71.25 1.55
15/06/20 Hartley Campbell Atkinson and Colin 72,031,609 72.60 69.82
15/06/20 The CRG Persons - 15.99 -
25/05/17 AFT Pharmaceuticals Limited - 72.34 -

Director’s Interests Announcements

Date Name No. Held % Details Other
18/09/23 Jon Lamb 271,314 - - -
14/04/21 Malcolm Tubby 143,892 - - -
10/08/20 Hartley Atkinson 72,899,435 - - -
03/07/20 David Flacks 178,764 - - -
22/08/18 James Burns 125,417 - - -
19/06/17 John Douglas Wilson 56,689 - - -

Analysts’ Forecasts

profit2021 profit2022 eps2021 dps2021 sales2021 ebit2021 ebitda2021
mean 13.7 13.1 2.0 191.3 22.0 24.6
high 13.7 13.1 2.0 191.3 22.0 24.6
low 13.7 13.1 2.0 191.3 22.0 24.6
sample 1 0 1 1 1 1 1

Disclaimer

Data on this page is from BusinessDesk and NZX Ltd for information purposes only. Details are believed to be accurate but no warranty is given as to accuracy, timeliness, reliability or completeness. No person should rely on the contents of the report and all persons should obtain independent professional advice before acting on any information connected with or contained in this report.
Last Updated: 04/07/2023


Markets News

The pros and cons of Sky’s big deal
Markets

Eden Bradfield: The pros and cons of Sky’s big deal

You'd best hope streaming and advertising revenue make up for the $1 purchase.

Eden Bradfield 26 Jul 2025
Markets Market Close

Infratil and Ebos help drive NZ stocks higher

Infrastructure investor helped the sharemarket end the week on a positive note.

Tom Raynel 25 Jul 2025
Infratil and Ebos help drive NZ stocks higher
Markets

Bathurst fails to strike-out Talley's claims

Talley's is alleging Companies Act breaches by its coal JV partner.

Pattrick Smellie 25 Jul 2025
Bathurst fails to strike-out Talley's claims
Markets

The fund riding a surge of golden visa cash

Punakaiki has raised more in a few months from visa applicants than all of 2025.

The fund riding a surge of golden visa cash
Markets

Stock & Trade: Is Karl Gradon’s Comvita gig worth the sting?

What do The Warehouse and Comvita have in common? 

Stock & Trade 25 Jul 2025
Is Karl Gradon’s Comvita gig worth the sting?